Cargando…
Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
BACKGROUND: Immunotherapies have advanced the treatment of metastatic melanoma; however, they are associated with immune-related toxicities. Patients with pre-existing autoimmune comorbidities are commonly excluded from clinical trials investigating immunotherapies in metastatic melanoma. Since info...
Autores principales: | Ma, Qiufei, Shilkrut, Mark, Zhao, Zhongyun, Li, Minming, Batty, Nicolas, Barber, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801837/ https://www.ncbi.nlm.nih.gov/pubmed/29409500 http://dx.doi.org/10.1186/s12885-018-4051-0 |
Ejemplares similares
-
Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis
por: Ma, Qiufei, et al.
Publicado: (2016) -
Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic Melanoma
por: Quinn, Casey, et al.
Publicado: (2016) -
Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison
por: Quinn, Casey, et al.
Publicado: (2016) -
Treatment Patterns in Patients with Metastatic Melanoma: A Retrospective Analysis
por: Zhao, Zhongyun, et al.
Publicado: (2014) -
Comorbid Conditions in Patients With Metastatic Colorectal Cancer
por: Fu, Alex Z, et al.
Publicado: (2011)